ISRG Key Statistics, Chart & Performance
The current stock price of ISRG is 488.835 USD. In the past month the price decreased by -19.58%. In the past year, price decreased by -18.3%.
ISRG Technical Analysis
ISRG Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ISRG. Both the health and profitability get an excellent rating, making ISRG a very profitable company, without any liquidiy or solvency issues.
ISRG Financial Highlights
Over the last trailing twelve months ISRG reported a non-GAAP Earnings per Share(EPS) of 8.93. The EPS increased by 21.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.58% | ||
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| Debt/Equity | 0 |
ISRG Forecast & Estimates
40 analysts have analysed ISRG and the average price target is 623.81 USD. This implies a price increase of 27.61% is expected in the next year compared to the current price of 488.835.
For the next year, analysts expect an EPS growth of 11.25% and a revenue growth 15.2% for ISRG
ISRG Ownership
ISRG Latest News, Press Relases and Analysis
ISRG Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.03 | 189.676B | ||
| SYK | STRYKER CORP | 23.66 | 138.597B | ||
| BSX | BOSTON SCIENTIFIC CORP | 22.24 | 115.097B | ||
| BDX | BECTON DICKINSON AND CO | 13.8 | 58.942B | ||
| IDXX | IDEXX LABORATORIES INC | 43.58 | 51.391B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.24 | 45.321B | ||
| RMD | RESMED INC | 22.08 | 38.981B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.46 | 37.494B | ||
| DXCM | DEXCOM INC | 27.63 | 27.258B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ISRG
Company Profile
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Company Info
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA 94086 US
CEO: Gary S. Guthart
Employees: 15638
Phone: 14085232100
INTUITIVE SURGICAL INC / ISRG FAQ
Can you describe the business of INTUITIVE SURGICAL INC?
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
What is the stock price of INTUITIVE SURGICAL INC today?
The current stock price of ISRG is 488.835 USD. The price increased by 2.63% in the last trading session.
Does INTUITIVE SURGICAL INC pay dividends?
ISRG does not pay a dividend.
What is the ChartMill rating of INTUITIVE SURGICAL INC stock?
ISRG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Where is INTUITIVE SURGICAL INC (ISRG) stock traded?
ISRG stock is listed on the Nasdaq exchange.
Can you provide the sector and industry classification for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (ISRG) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of ISRG stock?
INTUITIVE SURGICAL INC (ISRG) has a market capitalization of 173.29B USD. This makes ISRG a Large Cap stock.